These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35447492)

  • 41. Isolation, characterization using LC-ESI-QTOF, NMR and in vitro cytotoxicity assay of niclosamide forced degradation products.
    P J; Ch V; A L; V G M N; Ch N; N S
    J Pharm Biomed Anal; 2017 Mar; 136():148-155. PubMed ID: 28081501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and characterization of a photolytic degradation product of telmisartan using LC-MS/TOF, LC-MSn, LC-NMR and on-line H/D exchange mass studies.
    Shah RP; Singh S
    J Pharm Biomed Anal; 2010 Nov; 53(3):755-61. PubMed ID: 20554147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and characterization of forced degradation products of vortioxetine by LC/MS/MS and NMR.
    Ragi NC; Velma GR; Pallerla PK; Siddiqua S; Alugonda V; Rachamalla HKR; Pabbaraja S; Sripadi P
    J Pharm Biomed Anal; 2020 Sep; 188():113442. PubMed ID: 32622114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and Structural Characterization of Degradation Products of Linagliptin by Mass Spectrometry Techniques.
    Liana A; Hałuszczuk A; Gawor A; Bulska E
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study on structural characterization of degradation products of cangrelor using LC/QTOF/MS/MS and NMR.
    Guvvala V; Chidambaram Subramanian V; Anireddy JS
    J Pharm Biomed Anal; 2019 Jun; 170():327-334. PubMed ID: 30978606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive strategy for the rapid structure elucidation of drug degradants.
    Rourick RA; Volk KJ; Klohr SE; Spears T; Kerns EH; Lee MS
    J Pharm Biomed Anal; 1996 Sep; 14(12):1743-52. PubMed ID: 8887722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characterization of stress degradation products of sumatriptan succinate by using LC/Q-TOF-ESI-MS/MS and NMR: Toxicity evaluation of degradation products.
    Udutha S; Shankar G; Borkar RM; Kumar K; Srinivasulu G; Guntuku L; Naidu VGM; Srinivas R
    J Mass Spectrom; 2018 Oct; 53(10):963-975. PubMed ID: 29987857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Forced degradation of fingolimod: effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF-MS/MS and 1H NMR.
    Patel PN; Kalariya PD; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2015 Nov; 115():388-94. PubMed ID: 26279369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
    Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
    J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and characterization of stress degradation products of dronedarone hydrochloride employing LC-UV/PDA, LC-MS/TOF and MS(n) studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Jan; 118():139-148. PubMed ID: 26547261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study on forced degradation behaviour of dofetilide by LC-PDA and Q-TOF/MS/MS: Mechanistic explanations of hydrolytic, oxidative and photocatalytic rearrangement of degradation products.
    Thalluri B; Dhiman V; Tiwari S; Baira SM; Kumar Talluri MVN
    J Pharm Biomed Anal; 2020 Feb; 179():112985. PubMed ID: 31780282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of degradation products of midazolam maleate by UHPLC-HR-IT-MS
    Feng X; Du G; Hou T; Liu X; Chao R
    Pharmazie; 2017 Feb; 72(2):73-80. PubMed ID: 29441856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural elucidation of stress degradation products of ampicillin sodium by liquid chromatography/hybrid triple quadrupole linear ion trap mass spectrometry and liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry.
    Li T; Xu X; Fu S; Zhang J; Zhang K; Wang S; Zhao M; Ding W; Wang Q
    Rapid Commun Mass Spectrom; 2014 Sep; 28(17):1929-36. PubMed ID: 25088136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
    Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
    Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Separation and characterization of forced degradation products in homoharringtonine injection by UHPLC-Q-TOF-MS.
    Gu X; Chen Y; Lou Y; Zheng J
    J Pharm Biomed Anal; 2019 Nov; 176():112801. PubMed ID: 31430625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
    Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
    J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LC-UV and LC-MS evaluation of stress degradation behaviour of tenatoprazole.
    Mahadik M; Bhusari V; Kulkarni M; Dhaneshwar S
    J Pharm Biomed Anal; 2009 Dec; 50(5):787-93. PubMed ID: 19615841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
    Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
    J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MS2/TOF and LC-MS/TOF studies on toremifene to characterize its forced degradation products.
    Bansal G; Maddhesia PK; Bansal Y
    Analyst; 2011 Dec; 136(24):5218-28. PubMed ID: 22013582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.